We previously reported that patients with severe COVID-19 exhibit elevated urinary L-FABP levels upon admission [1], consistent with another study [10], which demonstrated that L-FABP levels in severe COVID-19 tend to increase shortly after symptom onset and remain elevated. The gene discussed is FABP1; the disease is COVID-19.